The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age

Human Reproduction

Volumn 32, Issue 1, 2017, Pages 119-124

  Tannus, Samer ^a   Son, Weon Young ^a   Gilman, Ashley ^a   Younes, Grace ^a   Shavit, Tal ^a   Dahan, Michael Haim ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

advanced maternal age; in vitro fertilization; intracytoplasmic sperm injection; live birth rate; non male factor infertility

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BLASTOCYST; CLINICAL OUTCOME; CONTROLLED STUDY; CRYOPRESERVATION; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; GROUPS BY AGE; HUMAN; HUMAN CELL; IN VITRO FERTILIZATION; IN VITRO OOCYTE MATURATION; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; MATERNAL AGE; METAPHASE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; RETROSPECTIVE STUDY; ZYGOTE; BIRTH RATE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

ADULT; BIRTH RATE; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; MATERNAL AGE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 85021140410     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dew298     Document Type: Article

References (25)

1. ASRM. Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion. Fertil Steril 2012; 98: 1395-1399.
2. Bhattacharya S, Hamilton MP, Shaaban M, Khalaf Y, Seddler M, Ghobara T, Braude P, Kennedy R, Rutherford A, Hartshorne G, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet 2001; 357: 2075-2079.
3. Boulet SL, Mehta A, Kissin DM, Warner L, Kawwass JF, Jamieson DJ. Trends in use of and reproductive outcomes associated with intracytoplasmic sperm injection. JAMA 2015; 313: 255-263.
4. Check JH, Chase DS, Horwath D, Yuan W, Garberi-Levito MC, Press M. Oocytes from women of advanced reproductive age do not appear to have an increased risk of zona pellucida hardening. Clin Exp Obstet Gynecol 2012; 39: 440-441.
5. Check JH, Yuan W, Garberi-Levito MC, Swenson K, McMonagle K. Effect of method of oocyte fertilization on fertilization, pregnancy and implantation rates in women with unexplained infertility. Clin Exp Obstet Gynecol 2011; 38: 203-205.
6. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16: 231-245.
7. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, Haan EA, Chan A. Reproductive technologies and the risk of birth defects. N Eng J Med 2012; 366: 1803-1813.
8. Dumoulin JM, Coonen E, Bras M, Bergers-Janssen JM, Ignoul-Vanvuchelen RC, van Wissen LC, Geraedts JP, Evers JL. Embryo development and chromosomal anomalies after ICSI: effect of the injection procedure. Hum Reprod 2001; 16: 306-312.
9. Dyer S, Chambers GM, de Mouzon J, Nygren KG, Zegers-Hochschild F, Mansour R, Ishihara O, Banker M, Adamson GD. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. Hum Reprod 2016; 31: 1588-1609.
10. Ebner T, Yaman C, Moser M, Sommergruber M, Jesacher K, Tews G. A prospective study on oocyte survival rate after ICSI: influence of injection technique and morphological features. J Assist Reprod Genet 2001; 18: 623-628.
11. Fishel S, Aslam I, Lisi F, Rinaldi L, Timson J, Jacobson M, Gobetz L, Green S, Campbell A, Lisi R. Should ICSI be the treatment of choice for all cases of in-vitro conception? Hum Reprod 2000; 15: 1278-1283.
12. Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J, Schoolcraft WB. Single blastocyst transfer: a prospective randomized trial. Fertil Steril 2004; 81: 551-555.
13. Hershlag A, Paine T, Kvapil G, Feng H, Napolitano B. In vitro fertilizationintracytoplasmic sperm injection split: an insemination method to prevent fertilization failure. Fertil Steril 2002; 77: 229-232.
14. Kim HH, Bundorf MK, Behr B, McCallum SW. Use and outcomes of intracytoplasmic sperm injection for non-male factor infertility. Fertil Steril 2007; 88: 622-628.
15. Korkmaz C, Tekin YB, Sakinci M, Ercan CM. Effects of maternal ageing on ICSI outcomes and embryo development in relation to oocytes morphological characteristics of birefringent structures. Zygote 2015; 23: 550-555.
16. Luna M, Bigelow C, Duke M, Ruman J, Sandler B, Grunfeld L, Copperman AB. Should ICSI be recommended routinely in patients with four or fewer oocytes retrieved? J Assist Reprod Genet 2011; 28: 911-915.
17. Mills M, Rindfuss RR, McDonald P, te Velde E. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update 2011; 17: 848-860.
18. Molloy D, Harrison K, Breen T, Hennessey J. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt. Fertil Steril 1991; 56: 285-289.
19. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992; 340: 17-18.
20. Roest J, Van Heusden AM, Zeilmaker GH, Verhoeff A. Treatment policy after poor fertilization in the first IVF cycle. J Assist Reprod Genet 1998; 15: 18-21.
21. Rosen MP, Shen S, Dobson AT, Fujimoto VY, McCulloch CE, Cedars MI. Oocyte degeneration after intracytoplasmic sperm injection: a multivariate analysis to assess its importance as a laboratory or clinical marker. Fertil Steril 2006; 85: 1736-1743.
22. Staessen C, Camus M, Clasen K, De Vos A, Van Steirteghem A. Conventional in-vitro fertilization versus intracytoplasmic sperm injection in sibling oocytes from couples with tubal infertility and normozoospermic semen. Hum Reprod 1999; 14: 2474-2479.
23. van Rumste MM, Evers JL, Farquhar CM. Intra-cytoplasmic sperm injection versus conventional techniques for oocyte insemination during in vitro fertilisation in patients with non-male subfertility. Cochrane Database Syst Rev 2003: CD001301.
24. Yavas Y, Roberge S, Khamsi F, Shirazi P, Endman MW, Wong JC. Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development. J Assist Reprod Genet 2001; 18: 426-435.
25. Yoeli R, Orvieto R, Ashkenazi J, Shelef M, Ben-Rafael Z, Bar-Hava I. Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes. J Assist Reprod Genet 2008; 25: 23-28.